Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
DALLAS, TX and MARTINSRIED, GERMANY / ACCESSWIRE / March 20, 2024 / Celanese Corporation (NYSE:CE), a global specialty materials and...
Implants
The Surface Treatment Of Medical Components With Mass Finishing & Shot Blasting
By Colin Spellacy, Head of Sales, Rösler UK In the demanding field of medical device manufacturing, the use of mass...
Monogram Orthopaedics to Host Business Update Conference Call on Thursday, March 21st at 5:00 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology...
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
U.S. Oral Surgery Management Enters Maryland, Adds Five New Partner Practices in Five States
USOSM President and CEO Richard Hall USOSM President and CEO Richard Hall says exceptional patient care and overall clinical excellence...
Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
Protocol AL is studying ILUVIEN or faricimab (6.0 mg) injections versus observation for the prevention of visual acuity loss due...
Monogram Orthopaedics Reports Full Year 2023 Financial Results
510(k) Submission with FDA On Track for Second Half of 2024Shipped mBôs Surgical Robot System to First International CustomerIntroduced mVision...
Ortho Development Receives FDA Clearance on Trivicta Hip System
DRAPER, UT / ACCESSWIRE / March 14, 2024 / Ortho Development Corporation, a designer and manufacturer of orthopedic implants and...
Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors
SCOTTSDALE, Ariz., March 08, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, a leading materials science platform that supports the design,...
Dental 3D Printing Market Size to Grow USD 1328.2 Million by 2030 at a CAGR of 16% | Valuates Reports
Dental 3D Printing Market is Segmented by Type (Desktop 3D Printer, Industrial 3D Printer), by Application (Dental Lab & Clinic, Hospital). BANGALORE,...
Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
Q4 Net Revenues up 88% to $26.3 million vs. Q4 20222023 Net Revenues up 49% to $80.8 million vs. 2022Increases...
IMPLANET Reports Its 2023 Full-Year Results
Governance evolution in line with the agreement with Sanyou Medical BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP,...
Accelus President & CEO Kevin McGann to Present at LSI USA ’24 Conference
Accelus President & Chief Executive Officer Kevin McGann Kevin McGann, Accelus President & CEO, has been named to the company's...
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
Full-Year 2023 Total Revenue Growth of 20% to $197.5 Million, with Adjusted EBITDA Growth of 40% Fourth Quarter Total Revenue...
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company...
Establishment Labs Announces Amended Credit Facility with Oaktree
- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®...
Establishment Labs Announces Amended Credit Facility with Oaktree
- Amendment of commercial and regulatory milestones for $50 million of additional non-dilutive capital to support launch of Motiva Implants®...
Tenon Medical, Inc. Announces Issuance of Notice of Allowance of Patent Application Which Further Enhances Important Claims for its Sacroiliac Joint Implant
Received Notice of Allowance from the USPTO on February 15, 2024LOS GATOS, CA / ACCESSWIRE / February 22, 2024 /...
CORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock
Raises Approximately $2.6 Million in Gross ProceedsRetires $1.25 Million in Secured DebtThis corrects and replaces the headline in the release...